CNO Financial (CNO) CMO sells 1,891 shares in planned Rule 10b5-1 trade

Rhea-AI Filing Summary

CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III sold 1,891 shares of common stock in an open-market transaction at a price of $51.31 per share. After this sale, he directly holds 77,300 shares of CNO common stock.

The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 24, 2026, indicating it was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 1,891 shares ($97,027)

Net Sell 1 txn

Insider Tarasi Rocco F. III

Role Chief Marketing Officer

Sold 1,891 shs ($97K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,891	$51.31	$97K

Holdings After Transaction: Common Stock — 77,300 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 1,891 shares Sale price: $51.31 per share Shares held after: 77,300 shares +2 more

5 metrics

Shares sold 1,891 shares Open-market sale of CNO common stock

Sale price $51.31 per share Price for CNO common stock sold

Shares held after 77,300 shares Direct CNO holdings post-transaction

Net share change -1,891 shares Net-sell direction in Form 4 summary

Trading plan adoption date February 24, 2026 Rule 10b5-1 plan referenced in footnote

Key Terms

Rule 10b5-1 trading plan, open-market sale, Form 4, non-derivative, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

""transaction_type": "non-derivative""

net-sell financial

""netBuySellDirection": "net-sell""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:09 PM Accepted by SEC EDGAR 07/01/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarasi Rocco F. III

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S		1,891(1)	D	$51.31	77,300	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CNO (CNO) report for Rocco F. Tarasi III?

CNO disclosed that Chief Marketing Officer Rocco F. Tarasi III sold 1,891 shares of common stock in an open-market transaction. The shares were sold at a price of $51.31 per share, according to the Form 4 insider trading report.

How many CNO (CNO) shares does the CMO hold after this Form 4 sale?

Following the reported sale, Chief Marketing Officer Rocco F. Tarasi III directly holds 77,300 shares of CNO common stock. This post-transaction balance is stated in the Form 4 and helps show the scale of the sale relative to his remaining ownership.

At what price were the CNO (CNO) shares sold in the latest insider trade?

The 1,891 CNO common shares were sold at an average price of $51.31 per share. This price reflects the consideration received in the open-market transaction reported on the Form 4 insider filing for CNO Financial Group.

Was the recent CNO (CNO) insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 footnote states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026. Such pre-arranged plans allow insiders to schedule trades in advance, reducing timing-related discretion.

Who is the insider involved in the latest CNO (CNO) Form 4 filing?

The insider is Rocco F. Tarasi III, who serves as Chief Marketing Officer of CNO Financial Group, Inc. He is listed as an officer, not a director or 10% owner, and reported the open-market sale of CNO common stock.